Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Personal Products Industry Analysis

UpdatedAug 28, 2026
DataAggregated Company Financials
Companies105
  • 7D5.5%
  • 3M18.2%
  • 1Y-5.0%
  • YTD5.2%

The Personal Products industry is up 5.5% in the last week, with Estée Lauder Companies up 10%. In contrast, the industry has lost 5.0% in the last 12 months. Looking forward, earnings are forecast to grow by 27% annually.

Industry Valuation and Performance

Has the U.S. Personal Products Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 29 Aug 2026US$93.9bUS$48.3bUS$744.7m15.6x126.1x1.9x
Mon, 27 Jul 2026US$83.3bUS$47.9bUS$708.6m16x117.5x1.7x
Wed, 24 Jun 2026US$82.0bUS$48.3bUS$693.7m18.4x118.2x1.7x
Fri, 22 May 2026US$76.3bUS$48.4bUS$752.9m16.2x101.4x1.6x
Sun, 19 Apr 2026US$78.6bUS$48.1bUS$614.6m22.3x127.9x1.6x
Tue, 17 Mar 2026US$81.9bUS$48.2bUS$678.5m22.1x120.7x1.7x
Thu, 12 Feb 2026US$90.3bUS$48.1bUS$974.7m20x92.7x1.9x
Sat, 10 Jan 2026US$91.8bUS$47.6bUS$350.3m21.4x262.1x1.9x
Mon, 08 Dec 2025US$90.0bUS$47.6bUS$351.3m23.6x256.1x1.9x
Wed, 05 Nov 2025US$87.2bUS$47.6bUS$505.3m21.7x172.6x1.8x
Fri, 03 Oct 2025US$87.5bUS$47.7bUS$307.3m20.2x284.9x1.8x
Sun, 31 Aug 2025US$100.8bUS$47.6bUS$303.5m22.4x332.1x2.1x
Tue, 29 Jul 2025US$103.7bUS$48.1bUS$108.9m22.7x952x2.2x
Thu, 26 Jun 2025US$96.2bUS$48.0bUS$109.5m17.3x878.4x2x
Sat, 24 May 2025US$93.9bUS$48.0bUS$113.1m17.4x830.4x2x
Mon, 21 Apr 2025US$84.4bUS$48.7bUS$556.7m23x151.6x1.7x
Wed, 19 Mar 2025US$92.8bUS$48.6bUS$349.8m29.8x265.2x1.9x
Fri, 14 Feb 2025US$89.1bUS$49.0bUS$374.4m24x238x1.8x
Sun, 12 Jan 2025US$94.9bUS$49.3bUS$1.5b24.9x64.3x1.9x
Tue, 10 Dec 2024US$104.6bUS$49.3bUS$1.5b30.5x70.8x2.1x
Thu, 07 Nov 2024US$97.4bUS$49.2bUS$1.4b28.4x68.8x2x
Sat, 05 Oct 2024US$115.6bUS$49.5bUS$1.6b26.8x71.5x2.3x
Mon, 02 Sep 2024US$109.7bUS$49.5bUS$1.6b22.1x67x2.2x
Wed, 31 Jul 2024US$108.4bUS$48.9bUS$2.4b22.8x44.9x2.2x
Fri, 28 Jun 2024US$113.2bUS$49.0bUS$2.4b21.6x46.7x2.3x
Sun, 26 May 2024US$118.1bUS$49.0bUS$2.4b21.2x48.7x2.4x
Tue, 23 Apr 2024US$124.7bUS$48.8bUS$2.5b25.1x49.2x2.6x
Thu, 21 Mar 2024US$130.6bUS$48.7bUS$2.5b24.5x52x2.7x
Sat, 17 Feb 2024US$128.0bUS$49.2bUS$2.5b29.8x51.1x2.6x
Mon, 15 Jan 2024US$126.4bUS$49.9bUS$2.7b26.7x47.7x2.5x
Wed, 13 Dec 2023US$122.8bUS$49.9bUS$2.6b27.1x46.6x2.5x
Fri, 10 Nov 2023US$107.4bUS$49.9bUS$2.7b24.1x40x2.2x
Sun, 08 Oct 2023US$120.9bUS$50.0bUS$3.3b23.8x36.9x2.4x
Tue, 05 Sep 2023US$137.2bUS$50.0bUS$3.3b21x41.8x2.7x
Price to Earnings Ratio

41.8x


Total Market Cap: US$137.2bTotal Earnings: US$3.3bTotal Revenue: US$50.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Personal Products Industry Price to Earnings3Y Average 177.6x202420252026
Current Industry PE
  • Investors are pessimistic on the American Personal Products industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 126x which is lower than its 3-year average PE of 177x.
  • The industry is trading close to its 3-year average PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Personal Products industry have declined 39% per year over the last three years.
  • Meanwhile revenues have remained mostly flat.
  • This means that although sales have remained flat, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Trends

Which industries have driven the changes within the U.S. Consumer Staples industry?

US Market1.16%
Consumer Staples-0.70%
Personal Products5.48%
Personal Products5.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
EL Estée Lauder CompaniesUS$103.391.4%
+US$524.6m		12.7%PE205.5x
KVUE KenvueUS$19.170.6%
+US$211.3m		-7.4%PE22.2x
ELF e.l.f. BeautyUS$104.102.1%
+US$127.5m		-16.7%PE103.1x
COTY CotyUS$2.854.0%
+US$96.9m		-33.4%PS0.4x
IPAR InterparfumsUS$117.781.9%
+US$69.8m		2.5%PE22.5x

Latest News

LFVN
US$6.36
LifeVantage
7D
-5.0%
1Y
-51.5%
ODD
US$14.35
Oddity Tech
7D
8.5%
1Y
-76.2%
HNST
US$5.67
Honest Company
7D
12.3%
1Y
43.2%
BHST
US$1.84
BioHarvest Sciences
7D
-10.5%
1Y
-77.5%
Narrative Update • Aug 26

BHST: CDMO Contract Shift Will Drive Long-Term Revenue From 2027

Analysts have reduced their fair value estimate for BioHarvest Sciences from $13.67 to $10.50. Recent research cites lower price targets tied to Q2 revenue shortfalls, reduced near-term guidance, and a shift in focus toward CDMO contracts that are expected to contribute more meaningfully from 2027.
KVUE
US$19.17
Kenvue
7D
0.6%
1Y
-7.4%
Seeking Alpha • Aug 24

Kenvue: Acquisition By Kimberly-Clark Hit An Obstacle - What Now

Summary Kenvue Inc. is being acquired by Kimberly-Clark in a mixed cash-and-stock deal, offering KVUE holders $19.71 per share. China’s SAMR has initiated a phase 2 antitrust review, potentially delaying the merger but not necessarily blocking it. The deal’s value for KVUE holders is highly sensitive to KMB’s share price, introducing significant volatility and risk. KVUE stock trades near intrinsic value; holding until deal closure offers diversification, but exiting now is reasonable if you dislike the merger. Read the full article on Seeking Alpha
NATR
US$14.21
Nature's Sunshine Products
7D
-0.9%
1Y
-15.7%
New Narrative • Aug 22

Digital Expansion Risks And Direct Selling Headwinds Will Gradually Support A Modest Recovery

Catalysts About Nature's Sunshine Products Nature's Sunshine Products sells nutritional supplements through direct selling and digital channels across North America, Asia Pacific, Europe and other regions. What are the underlying business or industry changes driving this perspective?
IPAR
US$117.78
Interparfums
7D
1.9%
1Y
2.5%
Narrative Update • Aug 21

IPAR: Asset Light Licensing And 2027 Runway Will Shape Fair 2026 Outlook

Interparfums' analyst fair value estimate has shifted from $109.33 to $126.67, as analysts balance higher modeled revenue growth and a richer future P/E of about 26.4x against tempered margin expectations and recent valuation driven rating downgrades across the Street. Analyst Commentary Recent Street research on Interparfums presents a split picture, with bullish analysts focusing on the company’s positioning in global fragrances and bearish analysts focusing on valuation and earnings risk into 2027.
EL
US$103.39
Estée Lauder Companies
7D
1.4%
1Y
12.7%
Narrative Update • Aug 20

EL: Turnaround Momentum And M&A Plans Will Shape Future Standalone Upside

Analysts have raised their price target for Estée Lauder Companies from $95.12 to $105.00, citing updated assumptions for revenue growth, profit margins, and future P/E, which are reflected in a slightly higher discount rate. What’s in the News for Estée Lauder Companies Estée Lauder Companies reported a strong fiscal Q3 2026, with EPS ahead of forecasts by 40% and double digit growth in fragrance sales, supported by its Beauty Reimagined turnaround plan and tighter cost control.
COTY
US$2.85
Coty
7D
4.0%
1Y
-33.4%
Narrative Update • Aug 20

COTY: Gucci License Exit And Coty Curated Reset Will Support Future Earnings Power

Analysts have trimmed their fair value estimate for Coty from $6.70 to $3.72 as they balance stronger recent Q4 sales and a modestly lower discount rate with questions about the pace of revenue growth, the impact of the Gucci license exit, and mixed price target signals that now range from $2.60 to $3.00. Analyst Commentary on Coty Recent Street research on Coty highlights a split view.
ELF
US$104.10
e.l.f. Beauty
7D
2.1%
1Y
-16.7%
HLF
US$12.43
Herbalife
7D
-1.7%
1Y
27.1%
Seeking Alpha • Aug 17

Herbalife Ltd.: The Share Price Is Discounting Terminal Decline

Summary Herbalife Ltd. is rated a 'risky' Buy, with shares trading at a steep discount and the market pricing in an overly pessimistic perpetual decline. HLF posted four consecutive quarters of YoY net sales growth, driven mainly by a one-off India GST cut, while other regions showed mixed or declining volume trends. Strategic repositioning toward personalized nutrition and deleveraging efforts are underway, with net leverage reduced to 2.2x and $45M in annual cash interest savings unlocked. Despite risks from GLP-1 adoption, growth concentration, leverage, and regulatory exposure, the current price offers potential upside versus a base case fair value near $24. Read the full article on Seeking Alpha
FTLF
US$9.79
FitLife Brands
7D
-2.3%
1Y
-47.4%
BRBR
US$10.69
BellRing Brands
7D
4.9%
1Y
-74.0%
Narrative Update • Aug 13

BRBR: Margin Headwinds And Governance Overhang Will Shape Recovery Expectations

BellRing Brands' fair value estimate has moved from $9.00 to $10.00 as analysts factor in higher price targets tied to strong demand across key product lines, tempered by recent margin pressures and updated long term profitability and P/E assumptions. Analyst Commentary Recent Street research on BellRing Brands points to a mixed setup, with several firms lifting price targets while also flagging clear execution and valuation risks.
NHTC
US$1.60
Natural Health Trends
7D
-5.3%
1Y
-63.6%
DSY
US$3.95
Big Tree Cloud Holdings
7D
-2.5%
1Y
-81.5%
ELAB
US$5.31
PMGC Holdings
7D
-20.3%
1Y
-99.6%